3,7-Dimethyloctanenitrile
Common Name: |
3,7-Dimethyloctanenitrile |
IUPAC Name: |
3,7-dimethyloctanenitrile |
Molecular Formula: |
C10H19N |
SMILES: |
CC(C)CCCC(C)CC#N |
Inchi: |
1S/C10H19N/c1-9(2)5-4-6-10(3)7-8-11/h9-10H,4-7H2,1-3H3 |
Inchi Key: |
SAPMLSXAXRULJB-UHFFFAOYSA-N |
Cas No: |
40188-41-8 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
1 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
2 |
Name |
Value |
Molecular Weight (g/mol) |
153.26 |
Mass (g/mol) |
153.152 |
Molar Refractivity |
49.93 |
Net Charge |
|
HBD |
|
HBA |
1 |
Rt Bonds |
5 |
Rings |
|
TPSA |
23.79 |
Hetero Atoms |
1 |
Heavy Atoms |
11 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
223.00 to 224.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.098 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.90 |
LogP |
3.362 |
iLOGP |
2.68 |
XLOGP3 |
3.67 |
WLOGP |
3.36 |
MLOGP |
2.70 |
ESOL Log S |
-2.77 |
ESOL Solubility (mg/ml) |
0.259 |
ESOL Solubility (mol/l) |
0.002 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-3.86 |
Ali Solubility (mg/ml) |
0.02 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-2.83 |
Silicos-IT Solubility (mg/ml) |
0.23 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-4.63 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.884 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.357 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |